Literature DB >> 23994534

Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study.

Taek Sang Lee1, Jung-Yun Lee, Jae-Weon Kim, Sohee Oh, Seok Ju Seong, Jong Min Lee, Tae Jin Kim, Chi Heum Cho, Seok-Mo Kim, Chan-Yong Park.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the impact of ovarian preservation on the recurrence and survival rates of premenopausal women with early-stage endometrial cancer.
METHODS: Using medical records of premenopausal women who received primary surgical treatment for stage I-II endometrial cancer, the demographics and survival rates were compared retrospectively for patients who had ovarian preservation and those who underwent bilateral salpingo-oophorectomy. Cox proportional hazards models with inverse probability of treatment weighting (IPTW) based on propensity score were performed to adjust for selection bias between the two groups.
RESULTS: A total of 495 women were identified, including 176 patients who had ovarian preservation. The ovarian preservation group was younger (P<0.001) and had an earlier year of diagnosis (P=0.014), a lower prevalence of lymphadenectomy (P<0.001), and a marginally significant association with lower tumor grade (P=0.052). The Kaplan-Meier curve and the log rank test showed no difference in either recurrence-free survival (P=0.742) or overall survival (P=0.462) between the two groups. In a multivariate Cox model adjusted by IPTW and covariates, ovarian preservation had no effect on either recurrence (hazard ratio [HR], 0.73; 95% CI, 0.29-1.81) or overall survival (HR, 1.33; 95% CI, 0.43-4.09).
CONCLUSIONS: Ovarian preservation does not appear to be associated with an adverse impact on the outcomes of premenopausal women with early-stage endometrial cancer. The present study has useful implications for physicians counseling young women who want to preserve their ovaries.
© 2013.

Entities:  

Keywords:  Endometrial cancer; Ovarian preservation; Premenopausal women

Mesh:

Year:  2013        PMID: 23994534     DOI: 10.1016/j.ygyno.2013.08.024

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

1.  Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer.

Authors:  Koji Matsuo; Marc R Gualtieri; Sigita S Cahoon; Carrie E Jung; Richard J Paulson; Donna Shoupe; Laila I Muderspach; Akihiko Wakatsuki; Jason D Wright; Lynda D Roman
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

Review 2.  New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.

Authors:  Honor J Hugo; C Saunders; R G Ramsay; E W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-21       Impact factor: 2.673

3.  Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer.

Authors:  Jason D Wright; Soledad Jorge; Ana I Tergas; June Y Hou; William M Burke; Yongmei Huang; Jim C Hu; Cande V Ananth; Alfred I Neugut; Dawn L Hershman
Journal:  Obstet Gynecol       Date:  2016-01       Impact factor: 7.661

Review 4.  The current clinical approach to newly diagnosed uterine cancer.

Authors:  Olga T Filippova; Mario M Leitao
Journal:  Expert Rev Anticancer Ther       Date:  2020-06-22       Impact factor: 4.512

5.  Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.

Authors:  Shin Wha Lee; Taek Sang Lee; Dae Gy Hong; Jae Hong No; Dong Choon Park; Jae Man Bae; Seok Ju Seong; So Jin Shin; Woong Ju; Keun Ho Lee; Yoo Kyung Lee; Hanbyoul Cho; Chulmin Lee; Jiheum Paek; Hyun Jung Kim; Jeong Won Lee; Jae Weon Kim; Duk Soo Bae
Journal:  J Gynecol Oncol       Date:  2016-10-27       Impact factor: 4.401

6.  Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation.

Authors:  A N Schüring; T Fehm; K Behringer; M Goeckenjan; P Wimberger; M Henes; J Henes; M F Fey; M von Wolff
Journal:  Arch Gynecol Obstet       Date:  2017-11-24       Impact factor: 2.344

Review 7.  Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer.

Authors:  Peng Jia; Yan Zhang
Journal:  Oncotarget       Date:  2017-06-07

8.  Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.

Authors:  Dimitrios Nasioudis; Eloise Chapman-Davis; Melissa Frey; Kevin Holcomb
Journal:  J Gynecol Oncol       Date:  2017-07       Impact factor: 4.401

9.  The survival effect of ovary preservation in early stage endometrial cancer: a single institution retrospective analysis.

Authors:  Wonkyo Shin; Sang-Yoon Park; Sokbom Kang; Myong Cheol Lim; Sang-Soo Seo
Journal:  J Ovarian Res       Date:  2020-08-22       Impact factor: 4.234

Review 10.  Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies.

Authors:  Roni Nitecki; Terri Woodard; J Alejandro Rauh-Hain
Journal:  Obstet Gynecol       Date:  2020-12       Impact factor: 7.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.